氯沙坦联合阿托伐他汀治疗老年高血压疗效及对延缓动脉硬化的作用研究
2018-01-31林新宇黄丽斯
林新宇+黄丽斯

【摘要】 目的 研究氯沙坦联合阿托伐他汀治疗老年高血压疗效及对延缓动脉硬化的作用。方法 300例老年高血压患者, 随机分为治疗组与对照组, 各150例。两组均口服阿司匹林肠溶片, 对照组在此基础上给予氯沙坦治疗, 治疗组在对照组基础上联合阿托伐他汀治疗。比较两组患者治疗前后的血压控制情况及颈动脉硬化改善情况。结果 治疗后, 两组收缩压(SBP)、舒张压(DBP)水平均低于治疗前, 且治疗组低于对照组, 差异有统计学意义(P<0.05)。治疗后, 两组颈动脉内中膜厚度(IMT)、斑块面积均小于治疗前, 差异有统计学意义(P<0.05);治疗组IMT(1.63±0.31)mm、斑块面积(0.61±0.17)cm2均小于对照组的(1.85±0.38)mm、(0.83±0.26)cm2, 差异有统计学意义(P<0.05)。结论 在老年高血压治疗中联合应用氯沙坦与阿托伐他汀, 可有效控制血压水平, 显著改善颈动脉硬化状况。
【关键词】 氯沙坦;阿托伐他汀;高血压;动脉硬化
DOI:10.14163/j.cnki.11-5547/r.2018.03.045
【Abstract】 Objective To study the efficacy of losartan and atorvastatin in the treatment of senile hypertension and study its effect on delaying arteriosclerosis. Methods A total of 300 senile patients with hypertension were randomly divided into treatment group and control group, with 150 cases in each group. Both groups received aspirin enteric-coated tablets. The control group was also treated with losartan, and the treatment group was treated with atorvastatin on the basis of the control group. Comparison were made on blood pressure control and improvement of carotid arteriosclerosis before and after treatment between two groups. Results After treatment, both groups had lower systolic blood pressure (SBP) and diastolic blood pressure (DBP) than before treatment, and the treatment group was lower than the control group. Their difference was statistically significant (P<0.05). After treatment, both groups had smaller carotid intima-media thickness (IMT) and plaque area than before treatment, and the difference was statistically significant (P<0.05). The treatment group had smaller IMT as (1.63±0.31) mm and plaque area as (0.61±0.17) cm2 than (1.85±0.38) mm and (0.83±0.26) cm2 in the control group, and the difference was statistically significant (P<0.05). Conclusion Combination of losartan and atorvastatin for senile hypertension can effectively control blood pressure level and significantly improve arteriosclerosis status.
【Key words】 Losartan; Atorvastatin; Hypertension; Arteriosclerosis
高血壓是高发于老年人群的一种心血管内科疾病, 摄入过多钠盐、精神紧张及大量饮酒等均为其常见病因[1]。若患者动脉血压长期处于较高水平, 常会导致其心、脑、肾等器官功能障碍, 严重者可引发心肌梗死、肾衰竭等并发症, 从而增加患者死亡发生风险[2]。此外, 有文献研究显示[3], 大多数老年高血压患者存在不同程度的颈动脉粥样硬化斑块, 当斑块组织发生脱落时易引起脑梗死。目前, 针对老年高血压临床治疗的主要目的为稳定降压、减少心脑血管不良事件的发生。氯沙坦是一种临床常用的降压药物, 通过口服给药方法能达到高效降压效果, 但单用此药物难以有效延缓动脉硬化发展[4]。阿托伐他汀属于降脂药物, 有研究指出[5], 联合应用氯沙坦与阿托伐他汀能显著降低血脂水平, 有效抗颈动脉硬化。本文将研究氯沙坦联合阿托伐他汀治疗老年高血压疗效及对延缓动脉硬化的作用, 现报告如下。……
